Compare National Beverage Corp. (FIZZ) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
National Beverage Corp. vs Medtronic PLC — how do they compare? National Beverage Corp. trades at $30.52 (market cap $2.89B), while Medtronic PLC trades at $88.79 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 38.8× National Beverage Corp.'s market cap, and Medtronic PLC pays a 3.28% dividend while National Beverage Corp. pays none. Which is the better fit depends on your goals — on Pluang, investors hold National Beverage Corp. for 33 Days and Medtronic PLC for 63 Days on average.
| FIZZ | MDT | |
|---|---|---|
Market Cap | $2.89B | $112.24B |
Volume | 553,950 | 105,663,236 |
Sector | Consumer Staples | Health |
52-Week High | $37.73 | $105.35 |
52-Week Low | $29.20 | $73.75 |
Typical Hold Time | 33 Days | 63 Days |
Enterprise Value | $2.84B | $131.58B |
Dividend Yield | — | 3.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
National Beverage Corp. (FIZZ) trades at $30.52, up 3.11% today, showing mixed signals with a bullish technical outlook but bearish analyst sentiment. The company reported flat revenue of $1.2B in 2025 with net income of $186.82M, while recent quarterly earnings have missed expectations. Technical indicators show support at $30 and resistance at $31, with RSI in neutral territory. Recent news highlights margin pressure from tariffs and a $3.25 special dividend payment.
FIZZ faces headwinds from stalled revenue growth and margin compression, though strong profitability metrics (40.13% ROE) provide some support. Analyst consensus is cautious with 50% sell ratings, while institutional activity shows mixed positioning. The stock's valuation appears reasonable at 16.58 P/E, but investors should monitor earnings recovery and competitive pressures in the beverage sector.
Medtronic (MDT) trades at $88.48, up 3.47% today, with a bullish analyst consensus and a $97.80 price target. The stock shows strong fundamentals with revenue growth to $33.54B in 2025 and a net income margin of 13.93%. Recent earnings beats and a 49-year dividend growth streak highlight operational strength, though technical indicators signal a near-term bearish trend with key support at $87.
MDT presents a compelling long-term investment with stable profitability and dividend reliability, but faces risks from debt increases and competitive pressures. Upside potential exists if the company maintains earnings momentum and executes on growth initiatives, while volatility may persist due to market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About National Beverage Corp.
National Beverage Corp is one of the top 10 non-alcoholic beverage companies in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls most of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store-delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants). It is controlled by chairman and CEO Nick Caporella, who owns over 73% of the common stock.
Read more on FIZZ →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
